Frequencies for first 10,000 rows of measurename variable in hqi_hosp_timelyeff

                           Measure Name |      Freq.     Percent        Cum.
----------------------------------------+-----------------------------------
Anticoagulation Therapy for Atrial Fi.. |        246        2.46        2.46
        Anticoagulation overlap therapy |        246        2.46        4.92
Antithrombotic Therapy by End of Hosp.. |        246        2.46        7.38
                     Aspirin at Arrival |        215        2.15        9.53
            Assessed for Rehabilitation |        245        2.45       11.98
   Discharged on Antithrombotic Therapy |        246        2.46       14.44
        Discharged on Statin Medication |        246        2.46       16.90
                Door to diagnostic eval |        215        2.15       19.05
                                    ED1 |        245        2.45       21.50
                                    ED2 |        245        2.45       23.95
            Emergency department volume |        246        2.46       26.41
Endoscopy/Polyp Surveillance: Appropr.. |        212        2.12       28.53
Endoscopy/Polyp Surveillance: Colonos.. |        212        2.12       30.65
             Evaluation of LVS Function |        254        2.54       33.19
Fibrinolytic Therapy Received Within .. |        254        2.54       35.73
Fibrinolytic Therapy Received Within .. |        215        2.15       37.88
                        Head CT results |        215        2.15       40.03
Healthcare workers given influenza va.. |        207        2.07       42.10
  Home Management Plan of Care Document |          8        0.08       42.18
Hospital acquired potentially prevent.. |        246        2.46       44.64
 ICU venous thromboembolism prophylaxis |        246        2.46       47.10
             Immunization for influenza |        254        2.54       49.64
Initial antibiotic selection for CAP .. |        253        2.53       52.17
                 Left before being seen |        212        2.12       54.29
                     Median Time to ECG |        215        2.15       56.44
            Median Time to Fibrinolysis |        215        2.15       58.59
Median Time to Transfer to Another Fa.. |        215        2.15       60.74
                Median time to pain med |        215        2.15       62.89
                                  OP 18 |        215        2.15       65.04
Percent of newborns whose deliveries .. |        246        2.46       67.50
 Postoperative Urinary Catheter Removal |        253        2.53       70.03
Primary PCI Received Within 90 Minute.. |        253        2.53       72.56
Prophylactic Antibiotic Selection for.. |        253        2.53       75.09
Prophylactic antibiotic received with.. |        254        2.54       77.63
Prophylactic antibiotics discontinued.. |        254        2.54       80.17
                       Stroke Education |        246        2.46       82.63
Surgery Patients Who Received Appropr.. |        254        2.54       85.17
Surgery Patients on a Beta Blocker Pr.. |        254        2.54       87.71
                   Thrombolytic Therapy |        246        2.46       90.17
Unfractionated heparin with dosages/p.. |        246        2.46       92.63
Venous Thromboembolism (VTE) Prophyla.. |        246        2.46       95.09
     Venous thromboembolism prophylaxis |        246        2.46       97.55
Warfarin therapy discharge instructions |        245        2.45      100.00
----------------------------------------+-----------------------------------
                                  Total |     10,000      100.00

by Jean Roth , jroth@nber.org , 15 Nov 2016